APA (7th ed.) Citation

Bors, A., Kozma, A., Tomán, Á., Őrfi, Z., Kondor, N., Tasnády, S., . . . Andrikovics, H. (2024). IGH: :NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma. Cancers, 16(2), 283. https://doi.org/10.3390/cancers16020283

Chicago Style (17th ed.) Citation

Bors, András, et al. "IGH: :NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma." Cancers 16, no. 2 (2024): 283. https://doi.org/10.3390/cancers16020283.

MLA (9th ed.) Citation

Bors, András, et al. "IGH: :NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma." Cancers, vol. 16, no. 2, 2024, p. 283, https://doi.org/10.3390/cancers16020283.